Cuxone SL 500mg/250mg Injection
Marketer
Cubit Healthcare
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cuxone SL 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, thereby curbing infection spread. Administration should strictly adhere to a healthcare provider's guidance. Complete the prescribed regimen; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report any worsening symptoms promptly. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your physician of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor before use. Alcohol consumption may potentiate drowsiness. While typically non-impairing, avoid driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and hydration facilitate recovery. Your doctor might order tests to monitor the medication's effects.
Uses of Cuxone SL 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cuxone SL 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Cuxone SL 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cuxone SL 500mg/250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cuxone SL 500mg/250mg Injection works:
Cuxone SL Injection (500mg/250mg) combines the antibiotic ceftriaxone with the beta-lactamase inhibitor sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counters bacterial resistance mechanisms, thereby boosting ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Cuxone SL 500mg/250mg Injection and alcohol consumption.
PregnancySAFE IF PRESCRIBED
The injectable medication Cuxone SL 500mg/250mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; however, data from human trials are scarce.
Breast feedingCAUTION
Administering Cuxone SL 500mg/250mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cuxone SL 500mg/250mg Injection can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cuxone SL 500mg/250mg Injection to individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Administering Cuxone SL 500mg/250mg Injection requires careful consideration in individuals with significant hepatic impairment. A modified dosage of Cuxone SL 500mg/250mg Injection may be necessary. Physician consultation is advised. Dosage modification for Cuxone SL 500mg/250mg Injection is generally unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cuxone SL 500mg/250mg Injection :
Omit doses of Cuxone SL 500mg/250mg Injection should prompt immediate physician consultation.
Facts to Know About Cuxone SL 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently